Meda Biotech LLC
Dr. Mewa Singh heads research and product development Meda Biotech llc. With over 24 years of experience in the field of biopharmaceuticals. He provides expertise in Biotechnology, product development and the pharmaceuticals business market. Over the time period of 24 years. He has successfully launched products for diagnostics, vaccines, nutraceuticals and nanomedicines. He has applied five patents and is founder of two biotech startups ( Meda Biotech llc and Nano Biotech (P) Ltd. He has performed at administrative and senior management positions which included Director of R&D, Chief Scientific Officer, and COO positions. He holds M.S. in Biochemistry, M Phil in Biochemistry , Microbiology and Immunology, and PhD in Microbiology and Immunology.. Developing over 160 Nanomedicines for Pharmaceuticals, Nutraceuticals and Agrochemicals, he has been working with the strength of conviction that a new concept of Hybrid drugs, is the solubility solution for insoluble drugs. His discovery of Hybrid-Nanoengineering™could have real significant therapeutic value for patients. This belief gave birth to a process of continual discovery and innovation, allowing him to develop many innovative medicines. Since 2002, his company Meda Biotech has been working to commercialize a technology that could make the treatment of cancer, pain and inflammation, more effective and less harmful to patients.
Product development in the field of ADC and Nanomedicnes.